Published in Crit Care on January 01, 2007
The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med (2013) 1.06
Volatile anesthetics improve survival after cecal ligation and puncture. Anesthesiology (2013) 1.05
Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care (2009) 0.98
Identifying which septic patients have increased mortality risk using severity scores: a cohort study. BMC Anesthesiol (2014) 0.89
Spot diagnosis: An ominous rash in a newborn. Ital J Pediatr (2009) 0.86
Diagnostic utility of broad range bacterial 16S rRNA gene PCR with degradation of human and free bacterial DNA in bloodstream infection is more sensitive than an in-house developed PCR without degradation of human and free bacterial DNA. Mediators Inflamm (2014) 0.75
Abstracts of the 27th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 27-30 march 2007. Crit Care (2007) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ (1998) 22.62
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med (2004) 12.79
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med (1998) 10.22
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ (1998) 6.80
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis (2004) 6.65
Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med (2004) 5.64
Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest (2006) 5.31
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet (2007) 4.81
Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest (2002) 4.71
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA (2003) 4.54
Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med (2005) 4.49
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med (1982) 4.28
Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med (2003) 4.25
Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet (2001) 4.17
Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis (2007) 4.16
Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (2006) 4.10
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis (2003) 4.09
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97
Emergency department overcrowding in the United States: an emerging threat to patient safety and public health. Emerg Med J (2003) 3.81
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med (2001) 3.40
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med (2004) 3.30
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis (2003) 3.20
Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med (2006) 3.18
Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med (2005) 2.82
The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med (2007) 2.80
Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest (2006) 2.69
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med (1994) 2.66
Transfusion-related acute lung injury. Blood (2004) 2.65
National Hospital Ambulatory Medical Care Survey: 2001 emergency department summary. Adv Data (2003) 2.64
Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal. Chest (2005) 2.58
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med (2001) 2.56
Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med (2007) 2.52
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med (2003) 2.44
The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet (1996) 2.41
The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care (2005) 2.31
Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med (1991) 2.28
Crisis in the emergency department. N Engl J Med (2006) 2.22
Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis (2002) 2.01
Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM (2005) 1.97
Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? Chest (2006) 1.96
Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med (2004) 1.96
Mortality in Emergency Department Sepsis (MEDS) score predicts 1-year mortality. Crit Care Med (2007) 1.94
Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med (1999) 1.91
Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med (2007) 1.88
Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis (2006) 1.76
Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med (2005) 1.76
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med (2004) 1.72
National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med (2006) 1.69
Intensive insulin in intensive care. N Engl J Med (2006) 1.68
Improved survival of critically ill cancer patients with septic shock. Intensive Care Med (2003) 1.49
A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest (2005) 1.39
Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis (2005) 1.35
Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care (2004) 1.30
Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest (2006) 1.29
Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med (2007) 1.28
Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med (2001) 1.26
New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care (2005) 1.24
Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care (2003) 1.24
Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med (2004) 1.23
Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Crit Care (2007) 1.18
Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care (2007) 1.15
Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med (2004) 1.15
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis (2003) 1.13
Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med (2006) 1.12
Effects of drotrecogin alfa (activated) in human endotoxemia. Shock (2004) 1.07
Quantitation of severity of critical illness with special reference to blood lactate. Crit Care Med (1974) 1.07
Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med (2004) 1.04
Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med (2006) 0.99
ICU-acquired nosocomial infection: impact of delay of adequate antibiotic treatment. Scand J Infect Dis (2002) 0.99
The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care (2007) 0.98
Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (2004) 0.98
Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock (2002) 0.90
[The design of the VISEP trial. Critical appraisal]. Anaesthesist (2007) 0.83
Early goal-directed therapy of septic shock in the emergency room: who could honestly remain skeptical? Crit Care Med (2006) 0.79
Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med (1995) 0.77
Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial. J Clin Epidemiol (2005) 0.76
Oxygen consumption during septic shock. Effects of inotropic drugs. Arch Int Physiol Biochim (1984) 0.75
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med (2008) 4.21
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18
Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation (2002) 3.16
Influence of overweight on ICU mortality: a prospective study. Chest (2004) 2.54
Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol (2002) 2.27
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25
Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med (2004) 2.05
High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol (2005) 1.56
[First steps towards a comparative evaluation of the French medical schools]. Presse Med (2009) 1.38
One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med (2004) 1.22
How emergency departments might alert for prehospital heat-related excess mortality? Crit Care (2006) 1.00
High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A (2005) 0.99
Anticoagulant therapy in acute lung injury. Crit Care Med (2003) 0.96
Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med (2004) 0.95
Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Crit Care Med (2003) 0.88
Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med (2008) 0.86
Risk factors for post-ICU red blood cell transfusion: a prospective study. Crit Care (2006) 0.84
Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis. Crit Care (2008) 0.83
Do ED staffs have a role to play in the prevention of repeat falls in elderly patients? Am J Emerg Med (2009) 0.81
Can metabolic abnormalities after a fall predict short term mortality in elderly patients? Eur J Epidemiol (2009) 0.77
The era of genomics: impact on sepsis clinical trial design. Crit Care Med (2002) 0.75
[Energize the university hospital]. Presse Med (2012) 0.75
Unblinding plan of PROWESS-SHOCK trial. Intensive Care Med (2011) 0.75
Health network to improve elderly patients' flow in emergency department. Eur J Emerg Med (2006) 0.75